Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2025-02-17 Major Shareholding Noti…
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified as an 'RNS Number' filing from the London Stock Exchange, which serves as a Primary Information Provider. The content is structured as a 'TR-1: Standard form for notification of major holdings' concerning 'Sankofa Strategic Equity Fund Limited' crossing a threshold of voting rights (6.57%) in 'Oxford BioDynamics plc'. This type of filing reports changes in significant share ownership, which corresponds directly to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2025-02-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled as an 'RNS Number' notification and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The content details the shareholder (Vulpes Investment Management Pte Ltd), the date the threshold was crossed (07-Feb-2025), and the resulting percentage of voting rights (12.870000%). This aligns perfectly with the 'Major Shareholding Notification' category (MRQ). Although it is an RNS filing, MRQ is the more specific classification.
2025-02-12 English
OBD partners with Regina Maria in Romania
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content describes a new distribution agreement between Oxford BioDynamics and Regina Maria for clinical tests in Romania. This is a material business development announcement, not a full financial report (like 10-K or IR), a transcript (CT), or a specific voting result (DVA). Since it is a general, material announcement distributed through the RNS system that doesn't fit perfectly into categories like ER, CAP, or MANG, the most appropriate classification is the general regulatory announcement category, RNS, as per the definitions provided.
2025-02-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as a 'TR-1: Standard form for notification of major holdings' and carries an 'RNS Number'. The content details the acquisition or disposal of voting rights by a specific person (William Henry Salomon) in Oxford BioDynamics PLC, crossing a threshold (3.065%). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2025-02-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2247W' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The filing date is 06-Feb-2025, and the event date is 05-Feb-2025. This specific regulatory filing type is classified under 'Major Shareholding Notification' (MRQ) in the provided schema, as it details the resulting situation of voting rights held by Spreadex LTD crossing a threshold.
2025-02-06 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2066W' and contains the standard boilerplate language associated with the London Stock Exchange's Regulatory News Service (RNS). The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in share ownership thresholds by an entity (Cantor Fitzgerald Europe). This type of filing, reporting changes in significant shareholdings, directly corresponds to the Major Shareholding Notification category (MRQ). Although RNS is the distribution mechanism, the specific content dictates the classification over the general RNS fallback.
2025-02-06 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.